Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection.
Puig I, López-Góngora S, Calvet X, Villoria A, Baylina M, Sanchez-Delgado J, Suarez D, García-Hernando V, Gisbert JP. Puig I, et al. Therap Adv Gastroenterol. 2016 Jul;9(4):437-48. doi: 10.1177/1756283X15621229. Epub 2015 Dec 16. Therap Adv Gastroenterol. 2016. PMID: 27366212 Free PMC article. Review.
The aim of this study was to perform a systematic review and meta-analysis evaluating the effectiveness and efficacy of SGT as third-line therapy. ...A qualitative analysis describing the current evidence and a pooled mean analysis summarizing the cure rates …
The aim of this study was to perform a systematic review and meta-analysis evaluating the effectiveness and efficacy of SGT as third- …
Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection.
López-Góngora S, Puig I, Calvet X, Villoria A, Baylina M, Muñoz N, Sanchez-Delgado J, Suarez D, García-Hernando V, Gisbert JP. López-Góngora S, et al. J Antimicrob Chemother. 2015 Sep;70(9):2447-55. doi: 10.1093/jac/dkv155. Epub 2015 Jun 14. J Antimicrob Chemother. 2015. PMID: 26078393 Review.
The aim of this study was to perform a systematic review and meta-analysis evaluating the efficacy of SGTs. METHODS: A systematic search was performed in multiple databases. ...A meta-analysis was performed using risk ratio (RR) and number needed to treat (NN …
The aim of this study was to perform a systematic review and meta-analysis evaluating the efficacy of SGTs. METHODS: A systema …
[Esophageal diseases: GERD, Barrett, achalasia and eosinophilic esophagitis].
Calvet X, Villoria A. Calvet X, et al. Gastroenterol Hepatol. 2014 Sep;37 Suppl 3:53-61. doi: 10.1016/S0210-5705(14)70083-4. Gastroenterol Hepatol. 2014. PMID: 25294266 Spanish.
Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.
Calvet X, Ruíz MÀ, Dosal A, Moreno L, López M, Figuerola A, Suarez D, Miquel M, Villoria A, Gené E. Calvet X, et al. PLoS One. 2012;7(9):e45604. doi: 10.1371/journal.pone.0045604. Epub 2012 Sep 21. PLoS One. 2012. PMID: 23029129 Free PMC article.
As FCM reduces the number of infusions required but is more expensive, we performed a cost-minimization analysis to compare the cost impact of the two drugs. ...A Monte Carlo simulation taking into account non-hospital direct costs favoured the use of FCM in 97% of …
As FCM reduces the number of infusions required but is more expensive, we performed a cost-minimization analysis to compare the cost …
[Use of intravenous iron infusion in a gastroenterology day hospital: Indications, dosage and adverse effects].
Dosal A, Calvet X, Moreno L, López M, Figuerola A, Ruíz MA, Suárez D, Gené E, Miquel M, Villoria A. Dosal A, et al. Gastroenterol Hepatol. 2010 Aug-Sep;33(7):479-83. doi: 10.1016/j.gastrohep.2010.02.011. Gastroenterol Hepatol. 2010. PMID: 20435381 Spanish.
RESULTS: During the study period, 111 patients (41% women, with a mean age of 63.8 ± 18 years) received intravenous iron infusions. ...The patients received a total of 557 iron infusions with a mean dose of 1033 mg iron per patient. There were no adverse effe …
RESULTS: During the study period, 111 patients (41% women, with a mean age of 63.8 ± 18 years) received intravenous iron infusions. . …
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study.
Soler JA, Güell M, Bricullé M, Gavarró A, Roig I, Sanchez J, Gisbert JP, García P, Villoria A, Calvet X. Soler JA, et al. Ann Hematol. 2009 Aug;88(8):769-73. doi: 10.1007/s00277-008-0684-4. Epub 2009 Jan 22. Ann Hematol. 2009. PMID: 19159929 Clinical Trial.
Monoclonal gammopathy of unknown significance (MGUS) is a chronic haematological alteration that carries a 1% risk per year of malignant evolution. ...This study evaluates the effect of H. pylori eradication in a cohort of 30 patients with MGUS. A 7-da …
Monoclonal gammopathy of unknown significance (MGUS) is a chronic haematological alteration that carries a 1% risk per year of …
[Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus, achalasia and eosinophilic esophagitis].
Calvet X, Villoria A. Calvet X, et al. Gastroenterol Hepatol. 2013 Oct;36 Suppl 2:51-6. doi: 10.1016/S0210-5705(13)70053-0. Gastroenterol Hepatol. 2013. PMID: 24160952 Spanish.
A highlight was confirmation of the high efficacy of weight loss to treat symptoms of reflux and an interesting pilot study suggesting that a simple ligature with supra- and infracardial bands could be an effective technique in esophageal reflux. ...Also of note thi
A highlight was confirmation of the high efficacy of weight loss to treat symptoms of reflux and an interesting pilot study suggestin
[Esophageal diseases: gastroesophageal reflux disease and Barrett's esophagus].
Calvet X, Villoria A. Calvet X, et al. Gastroenterol Hepatol. 2012 Sep;35 Suppl 1:26-34. doi: 10.1016/S0210-5705(12)70031-6. Gastroenterol Hepatol. 2012. PMID: 23018005 Spanish.
Furthermore, novel data suggest that undetected reflux plays a role in certain extraesophageal diseases. We also discuss the potential utility of impedanciometry of the esophageal mucosa in the diagnosis of GERD and review the management and implications of lack of respons …
Furthermore, novel data suggest that undetected reflux plays a role in certain extraesophageal diseases. We also discuss the potentia …
Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.
Villoria A, Garcia P, Calvet X, Gisbert JP, Vergara M. Villoria A, et al. Aliment Pharmacol Ther. 2008 Oct 1;28(7):868-77. doi: 10.1111/j.1365-2036.2008.03807.x. Epub 2008 Jul 17. Aliment Pharmacol Ther. 2008. PMID: 18644011
AIM: To evaluate the evidence on the usefulness of high-dose PPI in standard triple therapy by performing a systematic review and a meta-analysis. ...Randomized trials comparing a standard dose of a PPI with high-dose PPI both twice a day in tri …
AIM: To evaluate the evidence on the usefulness of high-dose PPI in standard triple therapy by performing a systematic review and …
45 results
Jump to page
Feedback